C

Clairvoyant Therapeutics Inc.

11 employees

Clairvoyant Therapeutics is a biotechnology company changing the face of psychedelic therapy with a speed-to-market clinical strategy.

Basic info

biotechnology research

Biotechnology

Pharmaceutical

drug development

alcohol use disorder

Therapeutics

psilocybin therapy

psychedelic research

clinical trials

2021

$1.9M

from 2 investors over 2 rounds

C

Clairvoyant Therapeutics Inc. raised undisclosed on July 7, 2022

Investors: Origin Therapeutics

C

Clairvoyant Therapeutics Inc. raised $1.9M on November 30, 2021

Investors: Negev Capital